CDC Resumes Johnson & Johnson Vaccine Use

As of Friday, the Centers for Disease and Control Prevention gave the go to resume the usage of the Johnson & Johnson COVID-19 vaccine after halting its administration due 6 reports of a rare blood clotting disorder occurring post-vaccine administration. The administration was resumed with a warning to women in general about the possibility of this rare side effect. 30 states have now resumed the use of this vaccine. This specific side effect was seen mostly in women between the ages of 18 and 49, those in this age range are advised to have caution when getting this vaccine or choose another one on the market.